Unione Europea - italiano - EMA (European Medicines Agency)

takeda pharmaceuticals international ag ireland branch - maribavir - infezioni da cytomegalovirus - antivirali per uso sistemico - livtencity is indicated for the treatment of cytomegalovirus (cmv) infection and/or disease that are refractory (with or without resistance) to one or more prior therapies, including ganciclovir, valganciclovir, cidofovir or foscarnet in adult patients who have undergone a haematopoietic stem cell transplant (hsct) or solid organ transplant (sot). dovrebbero essere prese in considerazione le linee guida ufficiali sull'uso appropriato degli agenti antivirali.

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

takeda pharma ag - maribavirum - compresse rivestite con film - maribavirum 200 mg, cellulosum microcristallinum, carboxymethylamylum natricum a, magnesii stearas, Überzug: poly(alcohol vinylicus) macrogolum 3350 e 171 talcum e 133 pro compresso obducto corresp. natrium max. 0.105 mg. - cmv infektion - synthetika